Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoid Tumor × gallium Ga 68 dotatate × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1 CNS 1

Conditions

Paraganglioma 2 Neuroendocrine Tumors 2 Tumor Positron-Emission Tomography 1 Pheochromocytoma 1 Neuroblastoma 1 Meningioma 1 Carcinoid Tumor 1

Interventions

olaparib 1 lutetium Lu 177 dotatate 1 gallium Ga 68 dotatate 1 Magnetic Resonance Spectroscopy 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02177773 2019-11-12

DOTA-TOC

University of California, San Francisco

Phase 1/2 Terminated

300 enrolled 5 charts

CNSEndocrineNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡